Drug Profile
KRP 110
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Kyorin Pharmaceutical
- Class
- Mechanism of Action Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Constipation; Pruritus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Constipation in Unknown (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pruritus in Unknown (PO)